Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Aussie Researchers Report Work On Multi-Cancer Vaccine

This article was originally published in PharmAsia News

Executive Summary

Australian scientists report development of a type of vaccine that could prevent 20 percent of all cancers and cure others by killing the chronic viral infectious diseases responsible. The University of South Australia professors said they are working on a platform technology capable of dealing with several of the cancer-causing diseases. The research, still in the preclinical stage, is on a method to deliver a safe, non-pathogenic virus through injections similar to that of vaccines that guard against cervical cancer. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069941

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel